Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Department of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
Tech Coloproctol. 2021 Jan;25(1):49-58. doi: 10.1007/s10151-020-02335-1. Epub 2020 Sep 3.
The current data on the intraoperative use of indocyanine green (ICG) fluorescence imaging to reduce the anastomotic leak (AL) rate in rectal cancer surgery remain controversial. The aim of this systematic review and meta-analysis was to evaluate the efficacy of ICG fluorescence imaging in decreasing the AL rate after rectal cancer surgery.
Studies comparing ICG fluorescence imaging with standard care in patients with rectal cancer were systematically searched from PubMed, Embase, Web of Science and Cochrane Library through January 2020. The current meta-analysis was performed according to the preferred reporting items for systematic review and meta-analysis guidelines. A pooled analysis was performed for the available data regarding the baseline features, AL rate and other surgical outcomes. RevMan version 5.3 software was used for the present meta-analysis.
Nine studies with a total of 2088 patients with rectal cancer (926 in the ICG group and 1162 in the control group) were included in the present study. In the pooled analysis, the available patient and tumour-related baseline data were all comparable and without significant heterogeneity. In the present pooled analysis, the AL rate in the ICG group was significantly lower (OR 0.34; 95% CI 0.22-0.52; p < 0.0001) than that in the control group. Additionally, intraoperative use of ICG was associated with a decreased overall complication rate (OR 0.57; 95% CI 0.42-0.78; p = 0.0003) and reduced reoperation rate (OR 0.26; 95% CI 0.08-0.86; p = 0.03) in patients who had rectal cancer surgery.
The present study demonstrated the superiority of the intraoperative use of ICG in reducing the AL rate. However, considering the limitations of the included studies, more high-quality prospective studies and randomized controlled trials are needed.
目前关于吲哚菁绿(ICG)荧光成像在降低直肠癌手术吻合口漏(AL)率方面的术中应用数据仍存在争议。本系统评价和荟萃分析的目的是评估 ICG 荧光成像在降低直肠癌手术后 AL 率方面的疗效。
从 PubMed、Embase、Web of Science 和 Cochrane Library 系统地搜索了比较直肠癌患者 ICG 荧光成像与标准护理的研究,检索时间截至 2020 年 1 月。本荟萃分析根据系统评价和荟萃分析指南的首选报告项目进行。对可用数据进行了汇总分析,包括基线特征、AL 率和其他手术结果。本荟萃分析采用 RevMan 版本 5.3 软件进行。
纳入了 9 项研究,共 2088 例直肠癌患者(ICG 组 926 例,对照组 1162 例)。在汇总分析中,可用的患者和肿瘤相关的基线数据均具有可比性,且无明显异质性。在本汇总分析中,ICG 组的 AL 率明显低于对照组(OR 0.34;95%CI 0.22-0.52;p<0.0001)。此外,术中使用 ICG 与降低总并发症发生率(OR 0.57;95%CI 0.42-0.78;p=0.0003)和降低直肠癌手术患者的再次手术率(OR 0.26;95%CI 0.08-0.86;p=0.03)相关。
本研究表明,术中使用 ICG 可降低 AL 率。然而,考虑到纳入研究的局限性,还需要更多高质量的前瞻性研究和随机对照试验。